Completed NA INTERVENTIONAL 2-arm NCT04801719

Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis

Endoluminal Radiofrequency Ablation of Tumors Affecting the Bile Ducts

Sponsor: Brno University Hospital

Conditions Biliary Tract Cancer Brachytherapy Radiofrequency Ablation Stent Complication

Interventions Habib™ EndoHPB; Boston Scientific, US; former EMcision Ltd., UK

Updated 3 times since 2021 Last updated: Mar 13, 2021 Started: Jan 4, 2010 Primary completion: Dec 31, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Biliary Tract Cancer and Brachytherapy and is currently completed. Brno University Hospital leads this study, which shows 3 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2021 — Jul 2024 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brno University Hospital

Data source: Brno University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brno, Czechia